<DOC>
	<DOCNO>NCT00392808</DOCNO>
	<brief_summary>The purpose study evaluate immune response toddler , booster dose second year life two meningococcal C conjugate polysaccharide vaccine , assess interchangeability two different vaccine .</brief_summary>
	<brief_title>Immunogenicity Booster Dose Two MenC Vaccines</brief_title>
	<detailed_description>Children 14 18 month life , previously vaccinate 2 dos tetanus toxoid conjugate polysaccharide men C vaccine three dos CRM197 conjugate polysaccharide men C vaccine 7 month age , randomize receive two vaccine . Serum antibody activity meningococcus C measure inmediately 4 week booster dose . Children also vaccinate combined vaccine contain DTaP+IPV+Hib .</detailed_description>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy toddler sex Toddlers 14 19 month age ( include day toddler 14 day 19 month age ) Children previously vaccinate two dos polysaccharide meningococcal C vaccine conjugate tetanus toxoid three dos polysaccharide meningococcal C conjugate CRM197 7 month age . Informed consent sign one parent adequately inform study . Toddlers severe disease axilar temperature ≥ 38,0ºC inclusion time Toddlers severe chronic disease Toddlers receive vaccine within last month program vaccination within 28 subsequent day administration vaccine study . Toddlers clinical bacteriological diagnosis previous meningococcal disease . Toddlers hypersensitivity component vaccine study antibiotic use manufacturing process could present non detectable trace ( streptomycin , neomycin , polymyxin B ) . Toddlers personal history convulsion . Toddlers know bleed disorder control Toddlers know congenital acquire immunodeficiency Toddlers receive receive treatment could change immune response ( administration intravenous immunoglobulin , systemic corticosteroid haemoderivates ) within 3 previous month . A toddler investigator opinion probable lose followup A toddler currently include plan include clinical trial . A toddler investigator opinion must include study due medical social reason .</criteria>
	<gender>All</gender>
	<minimum_age>14 Months</minimum_age>
	<maximum_age>19 Months</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Meningococcal vaccine</keyword>
	<keyword>Immunization , secondary</keyword>
	<keyword>vaccine conjugate</keyword>
	<keyword>Meningococcal disease</keyword>
</DOC>